Compare BridgeBio Pharma Inc (BBIO) vs JetBlue Airways Corporation (JBLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs JetBlue Airways Corporation — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while JetBlue Airways Corporation trades at $5.81 (market cap $2.19B). The key difference: BridgeBio Pharma Inc is far larger — about 7.5× JetBlue Airways Corporation's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals.
| BBIO | JBLU | |
|---|---|---|
Market Cap | $16.36B | $2.19B |
Sector | Health | Industrials |
52-Week High | $90.17 | $6.46 |
52-Week Low | $47.29 | $4.03 |
Enterprise Value | $18.14B | $9.56B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →
